Robotics Business Review

  • Home
  • Analysis / Opinion
    • RBR Analysis
    • RBR Opinion
    • RBR Interviews
  • Business
    • Management
    • Workforce
    • Start-Ups
      • RBR Start-Up Profiles
      • RBR Start-Up Insights
    • Social Good
    • Investment
    • Transaction Database
  • Markets / Industries
    • Agriculture
    • Construction / Demolition
    • Consumer
    • Defense / Security
    • Energy / Mining
    • Health / Medical
    • Logistics / Supply Chain
    • Manufacturing
    • Public Safety
    • Retail
    • Robotics Development
    • Utilities
  • Resources
    • Websites
      • The Robot Report
      • Mobile Robot Guide
      • Collaborative Robotics Trends
    • Webinars / Digital Events
    • Case Studies
    • Company Directory
    • Podcasts
    • Research
  • Events
    • RoboBusiness Direct
    • Robotics Summit
    • RoboBusiness
    • Healthcare Robotics Engineering Forum
    • R&D 100
  • RBR50
    • RBR50 2021 Nominations
    • RBR50 2020
      • RBR50 2020 Winners
      • RBR50 2020 Digital Edition
      • RBR50 2020 Company Listing

Titan Medical must raise $85M to bring Sport surgical robot to market

Titan Medical, which has delayed filing its Sport robot-assisted surgical system with the FDA, is looking for a buyer to help it commercialize Sport.

Titan Medical must raise $85M to bring Sport surgical robot to market

The Sport robot-assisted surgery system. Source: Titan Medical

By Nancy Crotti | February 4, 2020

Yesterday, David McNally, CEO of Titan Medical Inc., told shareholders that the company must raise $85 million to finish developing its Sport robot-assisted surgery device and file for clearance by the U.S. Food and Drug Administration.

The Toronto-based medical device company is considering raising that money through equity or debt, licensing, merger, or acquisition.

In August 2019, Titan Medical announced that it was delaying its submission of Sport to the FDA to further refine the system.

Titan Medical lost nearly half its value in October 2019 after suspending the timeline for bringing the device to market due to lack of funds. In November, the company put its research and development work on hold while it looked for funding.

In December, Aspire Capital Fund agreed to purchase up to $35 million of Titan’s common shares through June 23, 2022.

In the letter to shareholders, McNally spelled out the 12-year-old company’s strategy beyond paying its bills. Titan’s board of directors established a special committee of independent directors in January to oversee the search for financing, McNally said.

Titan Medical explains strategy

“If we are successful in securing sufficient financing, our planned next steps will be to restart and complete product development, proceed to product verification and validation, and submit an Investigative Device Exemption (IDE) application to the FDA to begin human confirmatory studies,” said McNally. “Preparation for IDE submission includes extensive planning for these studies, which is already in advanced stages having identified four hospitals and the key opinion-leading surgeons who will perform the studies.”

“We believe that the magnitude of the market opportunity justifies the investment of substantial human and financial capital to improve patient outcomes through single-port robotic surgery,” he added. “We remain committed to our search for the capital necessary to pursue our vision of delivering both patient and physician satisfaction through a product that, upon completion, we expect will be able to reduce trauma and deliver virtually scar-free surgery.”

For more coverage of Titan Medical, medical devices, and surgical robotics, visit Robotics Business Review‘s sibling sites, MassDevice and The Robot Report.

Related Articles Read More >

WIR-4-16-2021
RBR Essential Robotics Announcements – April 9 – 16, 2021
Charlie Duncheon
Robotics Entrepreneurship and Lessons Learned Earned – An Interview with Celltrio CEO Charlie Duncheon
Goldberg
Automating Robot-Assisted Surgical Subtasks – An Interview With UC Berkley’s Ken Goldberg
Ava Robotics
Intelligent Robots in the Workplace – Present and Future Outlook
The Robot Report Listing Database
Tweets by RoboticTips
Robotics Business Review
  • Advertising
  • Contact Us
  • Subscribe
  • Collaborative Robotics Trends
  • The Robot Report
  • Mobile Robot Guide
  • RoboBusiness Conference & Expo
  • Healthcare Robotics Engineering Forum
  • Robotics Summit Conference & Expo

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Robotics Business Review

  • Home
  • Analysis / Opinion
    • RBR Analysis
    • RBR Opinion
    • RBR Interviews
  • Business
    • Management
    • Workforce
    • Start-Ups
      • RBR Start-Up Profiles
      • RBR Start-Up Insights
    • Social Good
    • Investment
    • Transaction Database
  • Markets / Industries
    • Agriculture
    • Construction / Demolition
    • Consumer
    • Defense / Security
    • Energy / Mining
    • Health / Medical
    • Logistics / Supply Chain
    • Manufacturing
    • Public Safety
    • Retail
    • Robotics Development
    • Utilities
  • Resources
    • Websites
      • The Robot Report
      • Mobile Robot Guide
      • Collaborative Robotics Trends
    • Webinars / Digital Events
    • Case Studies
    • Company Directory
    • Podcasts
    • Research
  • Events
    • RoboBusiness Direct
    • Robotics Summit
    • RoboBusiness
    • Healthcare Robotics Engineering Forum
    • R&D 100
  • RBR50
    • RBR50 2021 Nominations
    • RBR50 2020
      • RBR50 2020 Winners
      • RBR50 2020 Digital Edition
      • RBR50 2020 Company Listing